Laboratory Corporation of America
Laboratory Corporation of America was paid $25K by Medicaid between Jan 2018 and Nov 2024, across 22 billing codes. Its largest line is 99199, Unlisted special service, procedure or report — 55% of everything it billed.
LOS ANGELES, CA 90015
Next to other Clinical Medical Laboratory providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,196 | $2K | |
| 2019 | 1,604 | $3K | |
| 2020 | 1,422 | $4K | |
| 2021 | 862 | $412.18 | |
| 2022 | 1,170 | $5K | |
| 2023 | 1,755 | $6K | |
| 2024incomplete | 1,579 | $5K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99199 | Unlisted special service, procedure or report | 55% | 2,757 | 2,516 | $14K |
| 80053 | Comprehensive metabolic panel | 12% | 1,530 | 1,377 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 12% | 2,149 | 1,968 | $3K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 5.7% | 46 | 46 | $1K |
| 82247 | 3.1% | 213 | 165 | $756.23 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.0% | 14 | 14 | $491.50 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.9% | 13 | 13 | $468.59 |
| 84443 | Thyroid stimulating hormone (TSH) | 1.4% | 23 | 23 | $336.03 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.1% | 13 | 13 | $282.75 |
| 80061 | Lipid panel | 1.1% | 24 | 24 | $274.08 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 12 | 12 | $243.12 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 22 | 22 | $185.90 |
10 more codes
| 85610 | <1% | 393 | $166.24 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 306 | $146.16 |
| 85730 | <1% | 209 | $144.49 | |
| 82248 | <1% | 72 | $140.95 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,165 | $135.14 |
| 86592 | <1% | 17 | $58.74 | |
| 81001 | <1% | 13 | $24.75 | |
| 81003 | <1% | 15 | $17.46 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 258 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 324 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.